Cargando…

Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19

Dexamethasone is the standard of care for critically ill patients with COVID-19, but the mechanisms by which it decreases mortality and its immunological effects in this setting are not understood. We performed bulk and single-cell RNA sequencing of the lower respiratory tract and blood, and plasma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neyton, Lucile P. A., Patel, Ravi K., Sarma, Aartik, Willmore, Andrew, Haller, Sidney C., Kangelaris, Kirsten N., Eckalbar, Walter L., Erle, David J., Krummel, Matthew F., Hendrickson, Carolyn M., Woodruff, Prescott G., Langelier, Charles R., Calfee, Carolyn S., Fragiadakis, Gabriela K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418533/ https://www.ncbi.nlm.nih.gov/pubmed/37577607 http://dx.doi.org/10.21203/rs.3.rs-3168149/v1

Ejemplares similares

Mass cytometry reveals a conserved immune trajectory of recovery in hospitalized COVID-19 patients
por: Burnett, Cassandra E., et al.
Publicado: (2022)

Metagenomic Sequencing in the ICU for Precision Diagnosis of Critical Infectious Illnesses
por: Neyton, Lucile P. A., et al.
Publicado: (2023)

COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone
por: Sarma, Aartik, et al.
Publicado: (2021)

A conserved immune trajectory of recovery in hospitalized COVID-19 patients
por: Burnett, Cassandra E., et al.
Publicado: (2022)

Tracheal aspirate RNA sequencing identifies distinct immunological features of COVID-19 ARDS
por: Sarma, Aartik, et al.
Publicado: (2021)

Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19
por: Wick, Katherine D., et al.
Publicado: (2022)

Integrated host-microbe plasma metagenomics for sepsis diagnosis in a prospective cohort of critically ill adults
por: Kalantar, Katrina L., et al.
Publicado: (2022)

Impaired immune signaling and changes in the lung microbiome precede secondary bacterial pneumonia in COVID-19
por: Tsitsiklis, Alexandra, et al.
Publicado: (2021)

COVID-19–associated Lung Microvascular Endotheliopathy: A “From the Bench” Perspective
por: Joffre, Jérémie, et al.
Publicado: (2022)

Immediate myeloid depot for SARS-CoV-2 in the human lung
por: Magnen, Mélia, et al.
Publicado: (2022)

Immediate myeloid depot for SARS-CoV-2 in the human lung
por: Magnen, Mélia, et al.
Publicado: (2022)

Latent Class Analysis-Derived Subphenotypes are Generalizable to Observational Cohorts of Acute Respiratory Distress Syndrome: A Prospective Study
por: Sinha, Pratik, et al.
Publicado: (2021)

Aerosolized nicotine from e-cigarettes alters gene expression, increases lung protein permeability, and impairs viral clearance in murine influenza infection
por: Maishan, Mazharul, et al.
Publicado: (2023)

Global Absence and Targeting of Protective Immune States in Severe COVID-19.
por: Combes, Alexis J., et al.
Publicado: (2020)

Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19
por: Combes, Alexis J., et al.
Publicado: (2021)

Plasma Metabolites in Early Sepsis Identify Distinct Clusters Defined by Plasma Lipids
por: Rogers, Angela J., et al.
Publicado: (2021)

Is there still a role for the lung injury score in the era of the Berlin definition ARDS?
por: Kangelaris, Kirsten Neudoerffer, et al.
Publicado: (2014)

A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
por: Hackney, Jason A., et al.
Publicado: (2023)

Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCs
por: van der Wijst, Monique G.P., et al.
Publicado: (2021)

Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
por: van der Wijst, Monique G. P., et al.
Publicado: (2021)

Intensive care unit scoring systems outperform emergency department scoring systems for mortality prediction in critically ill patients: a prospective cohort study
por: Moseson, Erika M, et al.
Publicado: (2014)

Acute respiratory distress syndrome-attributable mortality in critically ill patients with sepsis
por: Auriemma, Catherine L., et al.
Publicado: (2020)

The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium
por: Bonser, Luke R., et al.
Publicado: (2021)

One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome
por: Wang, Chen Yu, et al.
Publicado: (2014)

The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium
por: Bonser, Luke R., et al.
Publicado: (2022)

Prevalence of type-1 interferon autoantibodies in adults with non-COVID-19 acute respiratory failure
por: Ghale, Rajani, et al.
Publicado: (2022)

FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study
por: Zhang, MaryAnn, et al.
Publicado: (2011)

Fixing the leak: targeting the vascular endothelium in sepsis
por: Spicer, Aaron, et al.
Publicado: (2012)

Peeking under the Hood of Acute Respiratory Distress Syndrome Phenotypes: Deeper Insights into Biological Heterogeneity
por: Sinha, Pratik, et al.
Publicado: (2019)

Immunotherapy in COVID-19: why, who, and when?
por: Sinha, Pratik, et al.
Publicado: (2021)

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01
por: Weiner, January, et al.
Publicado: (2021)

Alternative Tobacco Product Use in Critically Ill Patients
por: Liu, Tom, et al.
Publicado: (2020)

Elevated plasma levels of TIMP-3 are associated with a higher risk of acute respiratory distress syndrome and death following severe isolated traumatic brain injury
por: Hendrickson, Carolyn M, et al.
Publicado: (2018)

Novel translational approaches to the search for precision therapies for acute respiratory distress syndrome
por: Meyer, Nuala J, et al.
Publicado: (2017)

ARDS Subphenotypes: Understanding a Heterogeneous Syndrome
por: Wilson, Jennifer G., et al.
Publicado: (2020)

Acute respiratory distress syndrome phenotypes with distinct clinical outcomes in PHARLAP trial cohort
por: Bihari, Shailesh, et al.
Publicado: (2023)

Early plasma angiopoietin-2 is prognostic for ARDS and mortality among critically ill patients with sepsis
por: Rosenberger, Carrie M., et al.
Publicado: (2023)

Upper airway gene expression differentiates COVID-19 from other acute respiratory illnesses and reveals suppression of innate immune responses by SARS-CoV-2
por: Mick, Eran, et al.
Publicado: (2020)

Acute respiratory distress syndrome
por: Meyer, Nuala J, et al.
Publicado: (2021)

Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis
por: Narla, Anupama, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_qqego1tvucr8f86ivikfaues1k